These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28462696)

  • 1. Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents.
    Rasouli Y; Davood A
    Curr Comput Aided Drug Des; 2018; 14(1):35-53. PubMed ID: 28462696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
    Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
    Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.
    Manvar AT; Pissurlenkar RR; Virsodia VR; Upadhyay KD; Manvar DR; Mishra AK; Acharya HD; Parecha AR; Dholakia CD; Shah AK; Coutinho EC
    Mol Divers; 2010 May; 14(2):285-305. PubMed ID: 19554465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
    Khoshneviszadeh M; Edraki N; Javidnia K; Alborzi A; Pourabbas B; Mardaneh J; Miri R
    Bioorg Med Chem; 2009 Feb; 17(4):1579-86. PubMed ID: 19162489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
    Desai NC; Trivedi AR; Somani HC; Bhatt KA
    Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.
    Desai B; Sureja D; Naliapara Y; Shah A; Saxena AK
    Bioorg Med Chem; 2001 Aug; 9(8):1993-8. PubMed ID: 11504636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
    Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.
    Kharkar PS; Desai B; Gaveria H; Varu B; Loriya R; Naliapara Y; Shah A; Kulkarni VM
    J Med Chem; 2002 Oct; 45(22):4858-67. PubMed ID: 12383011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
    Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V
    Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2D QSAR Analysis of Substituted Quinoxalines for their Antitubercular and Antileptospiral Activities.
    Natarajan R; Puratchikody A; Muralidharan V; Doble M; Subramani A
    Curr Comput Aided Drug Des; 2019; 15(2):182-192. PubMed ID: 30317999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tubercular drug development: computational strategies to identify potential compounds.
    Rajkhowa S; Jha AN; Deka RC
    J Mol Graph Model; 2015 Nov; 62():56-68. PubMed ID: 26386453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.
    Zhou XF; Shao Q; Coburn RA; Morris ME
    Pharm Res; 2005 Dec; 22(12):1989-96. PubMed ID: 16158213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in QSAR-based identification and design of anti-tubercular agents.
    Nidhi ; Siddiqi MI
    Curr Pharm Des; 2014; 20(27):4418-26. PubMed ID: 24245761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.
    Jardínez C; Vela A; Cruz-Borbolla J; Alvarez-Mendez RJ; Alvarado-Rodríguez JG
    J Mol Model; 2016 Dec; 22(12):296. PubMed ID: 27889884
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ničković VP; Vujnović-Živković ZN; Trajković R; Krtinić D; Ristić L; Radović M; Ćirić Z; Sokolović D; Veselinović AM
    J Biomol Struct Dyn; 2019 Aug; 37(12):3198-3205. PubMed ID: 30099932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
    Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
    Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR, docking studies of 1,3-thiazinan-3-yl isonicotinamide derivatives for antitubercular activity.
    Chitre TS; Asgaonkar KD; Patil SM; Kumar S; Khedkar VM; Garud DR
    Comput Biol Chem; 2017 Jun; 68():211-218. PubMed ID: 28411471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
    Virsodia V; Pissurlenkar RR; Manvar D; Dholakia C; Adlakha P; Shah A; Coutinho EC
    Eur J Med Chem; 2008 Oct; 43(10):2103-15. PubMed ID: 17950956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.